{"SPADE_N_15199": {"Sequence Information": {"Peptide Name": "Ogipeptin A", "Sequence": "XXXXXLR", "Sequence Length": 7, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anticancer", "Anti-Mammalian Cell"], "Binding Target": "1. Lipid Bilayer", "Source": "1. Pseudoalteromonas sp. SANK 71903", "Gene": "", "PDB ID": "", "UniProt Entry": [], "Literature": [{"Title": "Ogipeptins, novel inhibitors of LPS: physicochemical properties and structural elucidation.", "Pubmed ID": "27328866", "Reference": "J Antibiot (Tokyo). 2017;70:84-89", "Author": "Hirota-Takahata Y, Kozuma S, Kuraya N, Fukuda DS, Nakajima M, Takatsu T, Ando O", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/27328866"}, {"Title": "Identification and biological activity of ogipeptins, novel LPS inhibitors produced by marine bacterium.", "Pubmed ID": "27381520", "Reference": "J Antibiot (Tokyo). 2017;70:79-83", "Author": "Kozuma S, Hirota-Takahata Y, Fukuda DS, Kuraya N, Nakajima M, Ando O", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/27381520"}, {"Title": "Syntheses and antimicrobial activities of ogipeptin derivatives.", "Pubmed ID": "33964447", "Reference": "Bioorg Med Chem Lett. 2021;42:128093", "Author": "Takiguchi S, Homma H, Fujisawa T, Hirota-Takahata Y, Ono Y, Kizuka M, Ishii Y, Yoshimura S, Nishi T", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/33964447"}], "SPADE ID": "SPADE_N_15199", "Similar Sequences": [{"SPADE_ID": "SPADE_N_00011", "Similarity": 1.0, "Sequence": "STIVCVSLRICNWSLRFCPSFKVRCPM"}, {"SPADE_ID": "SPADE_N_00104", "Similarity": 1.0, "Sequence": "GAWKNFWSSLRKGFYDGEAGRAIRR"}, {"SPADE_ID": "SPADE_N_00129", "Similarity": 1.0, "Sequence": "RNKLAYNMGHYAGKATIFGLAAWALLA"}], "Hemolytic Activity": "Human embryonic kidney HEK293 cells:50% Cytotoxicity=>64 µg/ml", "Target Organism": "Escherichia coli ATCC 47076(MIC=0.25µg/ml),Escherichia coli NIHJ JC-2(MIC=0.25µg/ml),Staphylococcus aureus ATCC 6538P(MIC=128µg/ml),Staphylococcus epidermidis ATCC 14990(MIC=64µg/ml),Klebsiella pneumoniae ATCC 10031(MIC=1µg/ml),Acinetobacter baumannii ATCC 19606(MIC=2µg/ml),Pseudomonas aeruginosa ATCC 27853(MIC=4µg/ml),Pseudomonas aeruginosa ATCC 15692(MIC=64µg/ml),Klebsiella pneumoniae(MIC=1µg/ml),Acinetobacter baumannii(MIC=1µg/ml),Human hepatocellular carcinoma HepG2(50-60% Cytotoxicity=>64µg/ml),Escherichia coli(MIC=0.5µg/ml),Pseudomonas aeruginosa(MIC=0.5µg/ml)"}}}